Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 176(1): 77-81, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38085396

RESUMO

We showed for the first time that polymorphisms rs2075938 and rs2075938 of the NCF4 gene are associated with the risk of chronic heart failure in patients with type 2 diabetes mellitus (n=1310). In particular, haplotypes ATGTCTAT (OR=1.74, 95%CI=1.23-2.47; p=0.0017) and ATATTCAC (OR=2.83, 95%CI=1.33-6.03; p=0.0072) of NCF4 increase the risk of chronic heart failure in type 2 diabetes mellitus patients. The results show that NADPH oxidase subunit NCF4 is involved in the molecular mechanisms of myocardial damage in type 2 diabetes mellitus.


Assuntos
Diabetes Mellitus Tipo 2 , Insuficiência Cardíaca , Humanos , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/genética , Polimorfismo de Nucleotídeo Único/genética , NADPH Oxidases/genética , Haplótipos/genética , Insuficiência Cardíaca/genética , Predisposição Genética para Doença/genética
2.
3.
Bull Exp Biol Med ; 152(2): 213-5, 2011 Dec.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-22808463

RESUMO

Intragastric methionine (3 g/kg daily for 7 days) elevates homocysteine concentration and increases the endothelial dysfunction coefficient. This protocol of methionine treatment is an adequate model of hyperhomocysteine-induced endothelial dysfunction and can be used for studies of the endothelio- and cardioprotective effects of drugs.


Assuntos
Endotélio Vascular/patologia , Hiper-Homocisteinemia/fisiopatologia , Doenças Vasculares/fisiopatologia , Animais , Endotélio Vascular/efeitos dos fármacos , Hiper-Homocisteinemia/complicações , Hiper-Homocisteinemia/tratamento farmacológico , Metionina/uso terapêutico , Ratos , Doenças Vasculares/tratamento farmacológico , Doenças Vasculares/etiologia
4.
Antibiot Khimioter ; 42(3): 11-4, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9265460

RESUMO

The influence of immobilized proteases such as catalytin (a complex preparation containing the protease terrilytin and the antiseptic catapol) and streptodecase (an activator of fibrinolysis proteases) on the humoral immune response induced by the thymus-dependent antigen (SRBC) under conditions of burns and Staphylococcus infected burns was studied. The immobilized proteases catalytin and streptodecase had an immunostimulating effect under conditions of extended burns. Catalytin had an immunocorrigating effect under conditions of the infected burns. It was suggested that the complex enzyme-containing preparation catalytin and the immobilized activator of fibrinolysis proteases streptodecase were promising immunopharmacological agents in combined treatment of pathological processes accompanied by the development of immune deficiency as a secondary condition.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Amilases/uso terapêutico , Queimaduras/imunologia , Enzimas Imobilizadas/uso terapêutico , Fibrinolíticos/farmacologia , Peptídeo Hidrolases/uso terapêutico , Compostos de Amônio Quaternário/uso terapêutico , Estreptoquinase/farmacologia , Animais , Anti-Infecciosos Locais , Queimaduras/microbiologia , Ativação Enzimática , Tolerância Imunológica/efeitos dos fármacos , Ratos , Ratos Wistar , Infecções Estafilocócicas/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA